With growing Durham presence, Roivant lands $1.1B equity investment
August 09, 2017 at 18:12 PM EDT
As Roivant Sciences continues to expand its research and development-heavy outpost in Durham, the biopharmaceutical company has landed a $1.1 billion equity investment.